MYL10
Myosin regulatory light chain 10
Also known as: MGC3479, MYL10_HUMAN, MYLC2PL, PLRLC
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BUA6
- Gene
- MYL10
- Ensembl
- ENSG00000106436
- Chromosome
- 7
- Canonical length
- 226 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Microtubules
OverviewNCBI Gene
Predicted to enable calcium ion binding activity. Located in mitochondrion. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
226 residues, UniProt reviewed canonical sequence.
>Q9BUA6|MYL10
1 MLLRLVSNSW PQVILPPRPP KVLGLQAPRR ARKRAEGTAS SNVFSMFDQS QIQEFKESLA
61 LSPRLERNGM ISAHCNLCLT GSSNSPASAS QAFTIMDQNR DGFIDKEDLR DTFAALGRIN
121 VKNEELEAMV KEAPGPINFT VFLTMFGEKL KGTDPEETIL HAFKVFDTEG KGFVKADVIK
181 EKLMTQADRF SEEEVKQMFA AFPPDVCGNL DYRNLCYVIT HGEEKDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MYL10 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 1.3 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 1.3 nTPM
- choroid plexus: 0.8 nTPM
- pituitary gland: 0.8 nTPM
- placenta: 0.7 nTPM
- cervix: 0.6 nTPM
- prostate: 0.6 nTPM
Single-cell type
- epididymal principal cells: 11 nCPM
- peritubular myoid cells: 3.2 nCPM
- extravillous trophoblasts: 1.6 nCPM
- thymic myoid cells: 1.4 nCPM
- myosatellite cells: 1.2 nCPM
- somatotrophs: 1 nCPM
Immune cell
- basophil: 1.9 nTPM
- neutrophil: 1 nTPM
- T-reg: 0.4 nTPM
- memory B-cell: 0.3 nTPM
- naive B-cell: 0.3 nTPM
- NK-cell: 0.3 nTPM
Brain region
- cerebellum: 4.8 nTPM
- cerebral cortex: 4.2 nTPM
- white matter: 3.7 nTPM
- choroid plexus: 3.5 nTPM
- basal ganglia: 3.4 nTPM
- hippocampal formation: 3.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.02
- gnomAD pLI
- 0.01
- gnomAD missense Z
- -0.1
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MYL10 as an antibody target. Whether an autoantibody or antibody against MYL10 could matter depends on whether native MYL10 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MYL10 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MYL10 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...